Oxford Cannabinoid Technologies invests in research in pain and inflammation therapies, cancer treatments, and remedies for gastrointestinal diseases
Snoop Dogg has made a $10 million investment in a new medical cannabis research firm in the UK, through his venture capital firm Casa Verde.
It’s one of the largest investments into Oxford Cannabinoid Technologies, which has been seeking out funding for a research partnership and laboratory in Europe, Green Rush Daily reports.
Casa Verde Capital focuses on the “ancillary” cannabis industry, outside of the actual distribution of the plant, including health and wellness companies, financial services, media, agtech, and laboratory technology.
Its investment in OCT will support the company’s research in pain and inflammation therapies, cancer treatments, and remedies for gastrointestinal diseases.
Sir Patrick Stewart has also become a patron for the company, adding in a statement (via Metro): “I am proud to become a patron of OCT. It’s wonderful that OCT have got together the funding that means that Britain will lead the way in what is, in my view, one of the world’s most exciting fields of medical research. The possibilities seem to me to be virtually limitless.”
The actor has spoken in the past about using medical marijuana in the treatment of severe arthritis, advocating for UK-based research on cannabis-based medicines.
He will serve on OCT’s Advisory Board, with further appointments set to be announced.